1. Oncostatin M is a novel inhibitor of TGF-β1-induced matricellular protein expression.
- Author
-
Sarközi, Rita, Hauser, Christine, Noppert, Susie-Jane, Kronbichler, Andreas, Pirklbauer, Markus, Haller, Viktoria Maria, Grillari, Johannes, Grillari-Voglauer, Regina, Mayer, Gert, and Schramek, Herbert
- Subjects
- *
KIDNEY diseases , *PROTEINS , *CYTOKINES , *KIDNEY tubules , *PHOSPHORYLATION - Abstract
Matricellular proteins in the kidney have been associated with the development of tubulointerstitial fibrogenesis and the progression of renal disease. This study investigated potential antifibrotic effects of the cytokine oncostatin M (OSM) in human proximal tubule cells (PTC), particularly with regard to inhibition of profibrotic events initiated by TGF-β1. In human PTC, OSM diminished transforming growth factor (TGF)-β1-induced expression of the transcriptional epithelial-mesenchymal transition mediator FoxC2. Furthermore, exposure to OSM attenuated basal and TGF-β1-induced expression of the matricellular proteins SPARC, TSP-1, TNC, and CTGF regardless of the sequence of ligand administration. OSM was shown to result in rapid and sustained phosphorylation of both Stat1 and Stat3 and also in transient phosphorylation of Smad2/3 in contrast to TGF-β1, which demonstrated a gradually building phosphorylation of Smad2/3 and a brief phosphorylation of Smad1/5/8. Utilizing receptor-blocking molecules, we found the inhibitory effect of OSM on TGF-β1-induced CTGF mRNA expression occurs independently of Smad2/3 signaling and present evidence that this effect may be partially driven by OSM receptor-mediated Stat1 and/or Stat3 signaling pathways, thereby providing a mechanism whereby OSM can contribute to tubulointerstitial protection. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF